Difference between revisions of "VariationConciseDescriptions"

From WormBaseWiki
Jump to navigationJump to search
 
(26 intermediate revisions by the same user not shown)
Line 45: Line 45:
 
</pre>
 
</pre>
  
==Building summaries by sentences==
+
==Source files for project==
'''Source files for project'''
 
 
*obo_name_variation  tazendra home/postgres/work/pgpopulation/obo_oa_ontologies/geneace/obo_name_variation
 
*obo_name_variation  tazendra home/postgres/work/pgpopulation/obo_oa_ontologies/geneace/obo_name_variation
 
*obo_data_variation  tazendra home/postgres/work/pgpopulation/obo_oa_ontologies/geneace/obo_data_variation
 
*obo_data_variation  tazendra home/postgres/work/pgpopulation/obo_oa_ontologies/geneace/obo_data_variation
Line 54: Line 53:
 
*gin_seqname tazendra /home/postgres/work/pgpopulation/obo_oa_ontologies/geneace
 
*gin_seqname tazendra /home/postgres/work/pgpopulation/obo_oa_ontologies/geneace
  
===Building molecular info summary sentences===
+
==Building sentences==
 +
===Building Molecular sentence 1 ===
 
====Template for molecular sentence 1====
 
====Template for molecular sentence 1====
 
<variation> is a <app_nature> allele of <gene>.
 
<variation> is a <app_nature> allele of <gene>.
Example 1: "ju2 is a null allele of syd-1(F32D2.5)"
+
*Ex. "ju2 is a null allele of syd-1(F32D2.5)"
Example 2: "e1368 is a reduction-of-function/hypomorphic allele of the insulin/IGF receptor ortholog daf-2."
+
*Ex. "e1368 is a reduction-of-function/hypomorphic allele of daf-2."
  
====Sources for molecular sentence 1====
+
====Sources for molecular sentence 2====
 
* Source 1: geneace file on postgres
 
* Source 1: geneace file on postgres
 
** tazendra /home/postgres/work/pgpopulation/obo_oa_ontologies/geneace
 
** tazendra /home/postgres/work/pgpopulation/obo_oa_ontologies/geneace
Line 67: Line 67:
 
*Source 3: postgres table app_function
 
*Source 3: postgres table app_function
  
====Template for Molecular sentence 2====
+
===Building Molecular sentence 2A - gene features===
The <variation> is a <Molecular_change> that results in <> of <count of <Variation->Affects->"Transcript">.
+
Gene features include DNA binding sites, promoters, UTRs, splice sites
ex. The e1368 lesion is a missense mutation affecting 5 of 6 coding transcripts daf-2.
+
====Template for Molecular sentence -gene features====
 +
The <variation> is a <Molecular_change> in <gene feature> in <gene>.
 +
*Ex. tm3467 is a deletion mutation in a splice acceptor site in supr-1. (WBPaper00045690)
 +
====source tags====
 +
#Molecular_change tags:
 +
<pre>
 +
                      Splice_site Donor Text #Evidence
 +
                                  Acceptor Text #Evidence
 +
                      Frameshift Text #Evidence  // added sdm
 +
</pre>
 +
 
 +
===Building Molecular sentence 2B - gene processing===
 +
Gene processing effects include, truncation, frameshifts
 +
====Template for Molecular sentence -gene processing====
 +
The <variation> is a <Molecular_change> in <gene feature> in <gene>.
 +
*Ex. n3763 is a frameshift mutation in lin-35. (WBPaper00027336)
 +
*Ex. n767 is a silent mutation in lin-15. (WBPaper00001182)
 +
====source tags====
 +
#Molecular_change tags:
 +
<pre>
 +
                      Silent Text #Evidence
 +
                      Splice_site Donor Text #Evidence
 +
                                  Acceptor Text #Evidence
 +
                      Frameshift Text #Evidence  // added sdm
 +
                      Readthrough Text #Evidence // klh WS228
 +
</pre>
 +
 
 +
===Building Molecular sentence 2C - protein domains===
 +
Protein domains include catalytic sites, binding domains, activation domains etc.
 +
====Template for Molecular sentence -protein domains====
 +
The <variation> is a <Molecular_change> in the <protein domain> of <gene>.
 +
*Ex. gk291 is a deletion mutation in the PTB domain of dab-1. (WBPaper00031546)
 +
 
 +
 
 
====Sources for molecular sentence 2====
 
====Sources for molecular sentence 2====
 
* Source 1: geneace file on postgres
 
* Source 1: geneace file on postgres
 
**tazendra /home/postgres/work/pgpopulation/obo_oa_ontologies/geneace
 
**tazendra /home/postgres/work/pgpopulation/obo_oa_ontologies/geneace
* Source 2: TBD for molecular change
+
* Source 2: TBD for associated domain
  
 
Variation description tags needed for the above text:
 
Variation description tags needed for the above text:
Line 82: Line 115:
 
                                       Opal_UGA Text #Evidence
 
                                       Opal_UGA Text #Evidence
 
                       Missense Text #Evidence                // text fields stored details of codon change
 
                       Missense Text #Evidence                // text fields stored details of codon change
                      Silent Text #Evidence
 
                      Splice_site Donor Text #Evidence
 
                                  Acceptor Text #Evidence
 
                      Frameshift Text #Evidence  // added sdm
 
                      Readthrough Text #Evidence // klh WS228
 
 
</pre>
 
</pre>
* Source 3: TBD for transcript
+
=====problems=====
 +
*coding vs noncoding genes
 +
*mutation in noncoding area of gene
 +
*mutation affects isoforms differently
 +
*only use variations mapped onto human proteins, rather than other way around - keep in sync with with other projects, also limits sentence to a subset of isoforms?
 +
*..."that is or is not conserved in humans." can only use under limited situations, orthology needs to be done.
  
 
===Building gene process summary sentences===
 
===Building gene process summary sentences===
Line 117: Line 150:
 
WB WBGene00017066 maco-1 GO:0023041 WB_REF:WBPaper00038428|PMID:21589894 IMP WB:WBVar00597666|WB:WBVar00597667 P D2092.5 gene taxon:6239 20110824 WB
 
WB WBGene00017066 maco-1 GO:0023041 WB_REF:WBPaper00038428|PMID:21589894 IMP WB:WBVar00597666|WB:WBVar00597667 P D2092.5 gene taxon:6239 20110824 WB
 
</pre>
 
</pre>
 +
 
====Rules for Process sentence construction====
 
====Rules for Process sentence construction====
 
*'''Rule 1: '''Ignore all lines that do no have  "IMP" in column 7
 
*'''Rule 1: '''Ignore all lines that do no have  "IMP" in column 7
Line 141: Line 175:
 
   *'''nj34''' affects '''maco-1''' function in chemotaxis and neuronal signal transduction
 
   *'''nj34''' affects '''maco-1''' function in chemotaxis and neuronal signal transduction
  
===Building Phenotype Observed summary sentences===
+
===Building Phenotype Observed summary sentences using phenotype_association file===
  
 
====Template for Phenotype observed sentences====
 
====Template for Phenotype observed sentences====
 
<Variation> results in (defects, alterations) in <phenotype(s)>. <br>
 
<Variation> results in (defects, alterations) in <phenotype(s)>. <br>
Example: "e1368 disrupts DAF-2 processes of embryonic and larval development,  
+
Ex: "e1368 disrupts DAF-2 processes of embryonic and larval development,  
 
formation of the developmentally arrested dauer larval stage (diapause), adult  
 
formation of the developmentally arrested dauer larval stage (diapause), adult  
 
longevity, fat storage, salt chemotaxis learning, and stress resistance, including  
 
longevity, fat storage, salt chemotaxis learning, and stress resistance, including  
Line 170: Line 204:
  
 
</pre>
 
</pre>
====Rules for phenotype sentence construction====
+
====Rules for phenotype sentence construction using postgres tables====
'''Rule 1: '''For each line that does not contain a value in column 4, extract
+
'''Rule 1:''' For lines that does not contain a value in column 4,  
*variation(column 6 or 8),  
+
*extract variation(column 6 or 8),  
 
*phenotype (column 5)
 
*phenotype (column 5)
 
*paper(column 6)
 
*paper(column 6)
 
*ex. "WB:WBVar00143947" "WBPhenotype:0001861" "WBPaper00041295"
 
*ex. "WB:WBVar00143947" "WBPhenotype:0001861" "WBPaper00041295"
 
*Map WBVariationID to Variation public_name using obo_name_variation<br>
 
*Map WBVariationID to Variation public_name using obo_name_variation<br>
* Map WBPhenotype to Phenotype name using phenotype_ontology.WS251.obo<br>
+
*Map WBPhenotype to Phenotype name using phenotype_ontology.WS251.obo<br>
'''Rule 2: '''When more than one variation exists in a line create a new line and use only one variation, with same phenotype, NOT(if exists), and paper as original line<br>
+
'''Rule 2:''' When more than one variation exists in a line create a new line and use only one variation, with same phenotype, NOT(if exists), and paper as original line<br>
'''Rule 3: '''Pool all phenotypes for a given variation, comma separate<br>
+
'''Rule 3:''' Pool all phenotypes for a given variation, comma separate<br>
'''Rule 4: '''If a Phenotype term in the list is a parent of (is_a or part_of parent) another Phenotype term in the list, keep the most granular child term and ignore the parent term(s)
+
'''Rule 4:''' If a Phenotype term in the list is a parent of (is_a or part_of parent) another Phenotype term in the list, keep the most granular child term and ignore the parent term(s)<br>
'''Rule 5: '''Remove 'variant' from public names that have them<br>
+
 
 +
 
 +
===Building Phenotype Observed summary sentences using phenotype_association file===
 +
 
 +
====Template for Phenotype observed sentences====
 +
<Variation> results in (defects, alterations) in <phenotype(s)>. <br>
 +
Ex: "e1368 effects embryonic and larval development,
 +
formation of the developmentally arrested dauer larval stage (diapause), adult
 +
longevity, fat storage, salt chemotaxis learning, stress resistance, and
 +
response to high temperature. In addition, mutants have extended life spans. "
 +
 
 +
====Source files Phenotype Observed data====
 +
Source 1 postgres app tables:
 +
<pre>
 +
app_term
 +
app_variation
 +
app_paper
 +
</pre>
 +
*phenotype ontology ftp://ftp.wormbase.org/pub/wormbase/releases/WS251/ONTOLOGY/phenotype_ontology.WS251.obo (correct for latest release)
 +
*obo_name_variation tazendra home/postgres/work/pgpopulation/obo_oa_ontologies/geneace/obo_name_variation
 +
 
 +
====Rules for phenotype sentence construction====
 +
'''Rule 1:'''
 +
*extract variation - app_variation
 +
*phenotype - app_term
 +
*paper - app_paper
 +
*ex. "WB:WBVar00143947" "WBPhenotype:0001861" "WBPaper00041295"
 +
*Map WBVariationID to Variation public_name using obo_name_variation<br>
 +
*Map WBPhenotype to Phenotype name using phenotype_ontology.WS251.obo<br>
 +
'''Rule 2:''' When more than one variation exists in a line create a new line and use only one variation, with same phenotype, NOT(if exists), and paper as original line<br>
 +
'''Rule 3:''' Pool all phenotypes for a given variation, comma separate<br>
 +
'''Rule 4:''' If a Phenotype term in the list is a parent of (is_a or part_of parent) another Phenotype term in the list, keep the most granular child term and ignore the parent term(s)<br>
 +
'''Rule 5:''' Remove 'variant' from public names that have them<br>
 +
 
 +
====Rules for specific phenotype terms====
 +
'''Rule 1:''' For all terms that contain 'variant' remove 'variant' from public names that have them<br>
 +
'''Rule 2:''' For the following terms:
 +
* WBPhenotype:0000061 - extended life span
 +
* WBPhenotype:0001171 - shortened life span
 +
** add an "s" to the end of the term public name
 +
** use the phrasing "In addition, mutants have extended life spans."
 +
* WBPhenotype:0001838 - drug induced gene expression variant
 +
* WBPhenotype:0001871 - drug induced life span variant
 +
* WBPhenotype:0001872 - drug induced locomotion variant
 +
** change "induced" to "influenced"
 +
* Terms that end in "early emb"
 +
** replace "early emb" in the term with "in the early embryo"
 +
** for term WBPhenotype:0001185 "embryonic developmental delay early emb", remove "embryonic"
 +
** for term WBPhenotype:0001186 "embryo delayed at pronuclear contact early emb", remove the first term "embryo"
 +
 
 +
===Building Phenotype Attribute summary sentences===
 +
====Template for Phenotype Attribute summary sentences====
 +
<variation> is <app attribute>, <app attribute> <app_term>
 +
*Ex. "s1019 is cold-sensitive, maternal effect mid larval lethal;"
 +
 
 +
<variation> is <app attribute> <app_term> at <app_heat_temp> OR <variation> is <app attribute> <app term> at <
 +
*Ex. "e1368 is temperature sensitive dauer constitutive at 22.5 deg C;"
 +
 
 +
<variation> is <app attribute> for all phenotypes at <app_heat_degree> OR <variation> is <app attribute> for all phenotypes at <app_cold_degree>
 +
*Ex. "oj21 is temperature sensitive for all phenotypes at 25 deg C; "
 +
 
 +
<variation> is <app_mat_effect> <app_term>
 +
*Ex. "oj21 is maternal effect embryonic lethal;" 
 +
 +
====Source for Phenotype Attribute sentence====
 +
postgres app tables
 +
 
 +
====Rules for Phenotype Attribute summary sentences====
 +
'''Rule 1:''' when there are more than one phentoype attribute sentences, use the generic "animals" instead of repeating the allele name
 +
*Ex "oj21 is temperature sensitive for all phenotypes at 25 deg C; oj21 is maternal effect embryonic lethal; animals are 100% sterile at 25 degrees C;"
  
 
===Building Phenotype NOT Observed summary sentences===
 
===Building Phenotype NOT Observed summary sentences===
 
====Template for Phenotype NOT observed sentences====
 
====Template for Phenotype NOT observed sentences====
 
<Allele> does not show (defects, alterations) in <NOT phenotype(s)>.
 
<Allele> does not show (defects, alterations) in <NOT phenotype(s)>.
Example: "e1368 animals do not show any defects in acetylcholine esterase activity, carbon dioxide avoidance, diacetyl chemotaxis, and DMPP response."
+
*Ex. "e1368 animals do not show any defects in acetylcholine esterase activity, carbon dioxide avoidance, diacetyl chemotaxis, and DMPP response."
  
 
====Source files Phenotype Observed data====
 
====Source files Phenotype Observed data====
Line 204: Line 307:
 
WB WBGene00000898 daf-2 WBPhenotype:0000637 WB_REF:WBPaper00038179 IMP WB:WBVar00143947 P Y55D5A.5 gene taxon:6239 20151027 WB
 
WB WBGene00000898 daf-2 WBPhenotype:0000637 WB_REF:WBPaper00038179 IMP WB:WBVar00143947 P Y55D5A.5 gene taxon:6239 20151027 WB
 
</pre>
 
</pre>
====Rules for phenotype sentence construction
+
====Rules for phenotype sentence construction====
 
'''Rule 1:''' For each line that contains (NOT) value in column 4, extract  
 
'''Rule 1:''' For each line that contains (NOT) value in column 4, extract  
 
*variation(column 6 or 8),  
 
*variation(column 6 or 8),  
Line 218: Line 321:
 
'''Rule 5:''' Remove 'variant' from public names that have them<br>
 
'''Rule 5:''' Remove 'variant' from public names that have them<br>
  
===Building Phenotype Attribute summary sentences===
 
====Template for Phenotype Attribute summary sentences====
 
  
Example: "e1368 mutants are temperature sensitive and are dauer constitutive at 22.5 deg."
 
  
 
=== Building Disease Orthology summary sentences===
 
=== Building Disease Orthology summary sentences===
Line 261: Line 361:
  
 
==Prioritizing variations for automated descriptions==
 
==Prioritizing variations for automated descriptions==
* Classic alleles
+
*Classic alleles - Variations with Variation_type Allele (see [[WormBase_Model:Variation | Variation model]])
Variations with Variation_type Allele (see [[WormBase_Model:Variation | Variation model]])
+
**Alleles with molecular data => Variation_type Allele + Type_of_mutation exists
**Alleles with molecular data
+
**Alleles with only genetic data => Variation_type Allele and NO Type_of_mutation exists
***Variation_type Allele + Type_of_mutation exists
+
*Variations of genes with concise descriptions
**Alleles with only genetic data
+
**Variation Affects Gene + gene exists with cns_summary table entry; acedb model Gene->Gene_info->Concise_description
***Variation_type Allele and NO Type_of_mutation exists
+
*Other variation types
* Variations of genes with concise descriptions
+
**Variation_type SNP, Confirmed_SNP
**Variation Affects Gene + gene exists with cns_summary table entry; acedb model Gene->Gene_info->Concise_description
+
**Variation_type Transposons, RFLPs
* Other variation types
 
**Variation_type SNP, Confirmed_SNP
 
**Variation_type Transposons, RFLPs
 
 
*Engineered variations
 
*Engineered variations
** Variation_type Engineered_allele
+
**Variation_type Engineered_allele
 
* Integrated transgenes with allele name
 
* Integrated transgenes with allele name
* Variations that have been most published
+
*Variations that have been most published
 
**textpresso search results
 
**textpresso search results
* Variations with most phenotypes
+
*Variations with most phenotypes
 
**app_variation count
 
**app_variation count
  
==Semantic categories in an Automated Description==
+
==Orthology/ Conserved domain mutations==
===Molecular===
 
*Rationale: Molecular details
 
*Example:
 
*Model tags:
 
*Source files:
 
*Template sentence:
 
<Variation> is a(n) <Variation_type> in the <Species> <Gene>. This variation results in a <molecular summary> <Type_of_mutation> in the gene.
 
 
 
===Genetic===
 
* Gene function (null, hypomorph, etc. ->app_func)
 
* Allele nature (recessive, dominant, etc. ->app_nature)
 
* Phenotype
 
** Affects tissue expression, subcellular localization
 
** Affects gene regulation
 
** Affects gene interaction
 
* Orthology to human gene mutations related to disease
 
 
 
==Protein domain mutations==
 
 
see Caltech group meeting [[WormBase-Caltech_Weekly_Calls_May_2015 | May 7, 2015]] <br>
 
see Caltech group meeting [[WormBase-Caltech_Weekly_Calls_May_2015 | May 7, 2015]] <br>
 
connections between mutations and protein domains, and predict affects on function<br>
 
connections between mutations and protein domains, and predict affects on function<br>
Line 311: Line 390:
 
Sequencing of rab-14 in qx18 mutants revealed a C to T transition, which resulted in substitution of the Threonine at codon 67 with Methionine (ACG > ATG; T67M). This mutation affects the phosphate/Mg2+
 
Sequencing of rab-14 in qx18 mutants revealed a C to T transition, which resulted in substitution of the Threonine at codon 67 with Methionine (ACG > ATG; T67M). This mutation affects the phosphate/Mg2+
 
binding domain PM3, which is conserved in all members of the Ras GTPase superfamily
 
binding domain PM3, which is conserved in all members of the Ras GTPase superfamily
</pre>
 
  
<pre>
+
Sentences to make:
title : SYD-1, a presynaptic protein with PDZ, C2 and rhoGAP-like domains, specifies axon identity in C. elegans.
+
*Molecular sentence 2: "qx18 encodes a C to T transition, T67M which affects the phosphate/Mg2+ binding domain PM3"
id : WBPaper00005543
+
*Orthology sentence: "The phosphate/Mg2+ binding domain PM3 is conserved in all members of the Ras GTPase superfamily"
pdf : 5543_Hallam02.pdf
 
syd-1(GAPdeletion) mutation interferes with neurite outgrowth.
 
construct with various missense mutations as well as a deletion in the conserved rhoGAP domain in syd-1 were made and assessed for a phenotype in transgenic animals.
 
</pre>
 
 
 
<pre>
 
id : WBPaper00027028
 
name : WBPaper00027028
 
title : Conditional dominant mutations in the Caenorhabditis elegans gene act-2 identify cytoplasmic and muscle roles for a redundant actin isoform.
 
semidominant and embryonic-lethal mutations in the C. elegans act-2 gene. These mutations alter conserved amino acids in the predicted ATP binding pocket of actin and promote contractile instabilities and ectopic furrowing in early embryonic cells, implicating ACT-2 as a cytoplasmic
 
actin.
 
</pre>
 
 
 
<pre>
 
Title: The Caenorhabditis elegans Iodotyrosine Deiodinase Ortholog SUP-18 Functions through a Conserved Channel SC-Box to Regulate the Muscle Two-Pore Domain Potassium Channel SUP-9 .
 
Authors: de la Cruz IP ; Ma L ; Horvitz HR
 
Journal: PLoS Genet
 
Year: 2014-02
 
Doc ID: WBPaper00044940
 
SECTION: discussion. Five other sup-18 mutations affecting highly conserved residues in the NADH oxidase / flavin reductase domain also behave like null mutations , consistent with the hypothesis that SUP-18 enzymatic activity is essential for its function.
 
SECTION: discussion. While Kvb2 knockout mice have seizures and reduced lifespans , mice carrying a catalytic null mutation in Kvb2 have a wild-type phenotype , suggesting that if an enzymatic activity for Kvb2 exists , it is functionally dispensable SUP-18 Interacts with a Two-Pore Domain K + Channel PLOS Genetics | www . plosgenetics . org 11 February 2014 | Volume 10 | Issue 2 | e1004175 in vivo [ 59 ] .
 
IYDs across metazoan species share a similar enzymatic activity in reductive deiodination of diiodotyrosine [51], and it seems likely that SUP-18 acts similarly in C. elegans. Like mammalian IYDs,
 
SUP-18 contains a presumptive N-terminal transmembrane domain that is required for full activity. Interestingly, the SUP-18 intracellular region lacking the transmembrane domain could still partially activate the SUP-9 channel, suggesting that membrane association is not absolutely required for SUP-9 activation by SUP-18. Membrane association is important for mammalian IYD enzymatic activities [5,52,53].
 
 
</pre>
 
</pre>
  
Line 349: Line 404:
 
Doc ID: WBPaper00002191
 
Doc ID: WBPaper00002191
 
When the n1619 mutation , which confers a lethal and highly penetrant vulvaless phenotype in C . elegans , is introduced into the c-abl SH3 domain , substituting a leucine for proline at AN amino acid number 131 , the resulting mutant transforms NIH3T3 fibroblasts with an efficiency about 10 % that of SH3-deleted c-abl .
 
When the n1619 mutation , which confers a lethal and highly penetrant vulvaless phenotype in C . elegans , is introduced into the c-abl SH3 domain , substituting a leucine for proline at AN amino acid number 131 , the resulting mutant transforms NIH3T3 fibroblasts with an efficiency about 10 % that of SH3-deleted c-abl .
 +
 +
Sentence to make:
 +
*Molecular sentence 2: "n1619 encodes a L131P substitution in the c-abl SH3 domain"
 
</pre>
 
</pre>
  
Line 360: Line 418:
 
SECTION: results. In the gain-of-function ced-9 ( n1950sd ) allele , glycine 169 , which resides in the CED-9 BH3 binding pocket , is mutated to glutamate ( G169E ) . [Field: results, subscore: 3.00]
 
SECTION: results. In the gain-of-function ced-9 ( n1950sd ) allele , glycine 169 , which resides in the CED-9 BH3 binding pocket , is mutated to glutamate ( G169E ) . [Field: results, subscore: 3.00]
 
SECTION: results. To test whether co-expression of DRP-1 modulates CED-9 via interactions with the BH3 binding pocket , we first created a construct corresponding to the ced- 9 ( n1950gf ) allele .
 
SECTION: results. To test whether co-expression of DRP-1 modulates CED-9 via interactions with the BH3 binding pocket , we first created a construct corresponding to the ced- 9 ( n1950gf ) allele .
</pre>
 
 
<pre>
 
Schwartz, 2010, WBPaper00036020
 
“Since the HMT-1 polypeptide of gk161 allele lacked TMD and NBD that are required for the function of ABC transporters, we used this strain in our studies.” gk161 is hypersensitive to cadmium
 
</pre>
 
  
<pre>
+
Sentence to make:
WBPaper0002481 Wang 1996
+
*Molecular sentence 2: "n1950 encodes a G169E change in the BH3 binding pocket of CED-9"
identifies unc-86 binding sites in mec-3 promoter region, with accompanying evaluation of phenotypes resulting from mec-3 mutations in these regions
 
“UNC-86 binding is blocked by certain mutations, as described above. When met-3-lacZ fusions with UNC-86 site mutations were introduced into C. elegans, mutations in Region III had a strong effect on expression, mutations in Region II had a significant effect, and mutations in Region I had no detectable effect”
 
 
</pre>
 
</pre>
  
Line 378: Line 428:
 
“In conjunction with molecular modeling , our data suggest that the C . elegans mutation as well as an equivalent mutation in human SOS1 activate the MAPK pathway by disrupting an auto-inhibitory function of the Dbl domain on Ras activation “
 
“In conjunction with molecular modeling , our data suggest that the C . elegans mutation as well as an equivalent mutation in human SOS1 activate the MAPK pathway by disrupting an auto-inhibitory function of the Dbl domain on Ras activation “
 
“A mutation equivalent to sy262 G322R activates hSOS1.”
 
“A mutation equivalent to sy262 G322R activates hSOS1.”
“...in every experiment we found that at some time point, hSOS1 C282R dis- played two- to fourfold more activity than wild-type hSOS1. In conjunction with our genetic data, these data suggest that the G322R change in C. elegans SOS-1, as well as the equivalent C282R change in hSOS1, does indeed enhance EGF-depen- dent MAPK activation.”
+
“...in every experiment we found that at some time point, hSOS1 C282R dis- played two- to fourfold more activity than wild-type hSOS1. In conjunction with our genetic data, these data suggest that the G322R change in C. elegans SOS-1, as well as the equivalent C282R change in hSOS1, does indeed enhance EGF-dependent MAPK activation.”
 +
 
 +
Sentence to make:
 +
*Molecular sentence 2: "sy262 encodes a G33R mutation in the Rac GEF Dbl domain and is equivalent to a C282R change in the human hSOS1."
 +
*Orthology sentence: "The sy262 G33R mutation is equivalent to a C282R change in the human hSOS1."
 
</pre>
 
</pre>
  
Line 388: Line 442:
 
Doc ID: WBPaper00003954
 
Doc ID: WBPaper00003954
 
results. The region surrounding the conserved valine ( bold ) that is mutated to a glutamate in the ad1302 allele ( resulting from a T to A mutation in the second base of the V60 codon ) is shown lined up with the corresponding region in other GluCl subunits and in the rat glycine and -aminobutyric acid ( GABA ) type A- channel subunits ( 29 , 30 ) . [Field: results]
 
results. The region surrounding the conserved valine ( bold ) that is mutated to a glutamate in the ad1302 allele ( resulting from a T to A mutation in the second base of the V60 codon ) is shown lined up with the corresponding region in other GluCl subunits and in the rat glycine and -aminobutyric acid ( GABA ) type A- channel subunits ( 29 , 30 ) . [Field: results]
 +
 +
Sentence to make:
 +
*Molecular sentence 2: "ad1302 encodes a Val to Glu change."
 +
*Orthology sentence: "ad1302 affects a region that is conserved in GluCl subunits as well as in rat glycine and GABA type A-channel subunits."
 
</pre>
 
</pre>
 
  
 
<pre>
 
<pre>
Line 400: Line 457:
 
SECTION: discussion. This mutation alters a conserved amino acid in the HMG box DNA binding domain which is conserved specifically in TCF / LEF- 1 type HMG proteins ( Laudet et al . , 1993 ) , suggesting that the pop-1 ( q624 ) mutation may affect either recognition of the TCF / LEF-1 consensus sequence or DNA binding affinity , thereby lowering POP-1 activity . [Field: discussion]
 
SECTION: discussion. This mutation alters a conserved amino acid in the HMG box DNA binding domain which is conserved specifically in TCF / LEF- 1 type HMG proteins ( Laudet et al . , 1993 ) , suggesting that the pop-1 ( q624 ) mutation may affect either recognition of the TCF / LEF-1 consensus sequence or DNA binding affinity , thereby lowering POP-1 activity . [Field: discussion]
 
SECTION: discussion. As the only mutation isolated thus far in a developmental system that changes a highly conserved amino acid in the -catenin binding domain , the pop-1 ( q645 ) missense mutation may shed new light on TCF / LEF-1 function during development . [Field: discussion]
 
SECTION: discussion. As the only mutation isolated thus far in a developmental system that changes a highly conserved amino acid in the -catenin binding domain , the pop-1 ( q645 ) missense mutation may shed new light on TCF / LEF-1 function during development . [Field: discussion]
SECTION: introduction. The pop-1 ( q624 ) allele is weakly penetrant for multiple defects and appears to be a partial loss-offunction mutation ; pop-1 ( q624 ) alters a conserved amino acid in the HMG-box DNA binding domain . [Field: introduction]
+
SECTION: introduction. The pop-1 ( q624 ) allele is weakly penetrant for multiple defects and appears to be a partial loss-of function mutation ; pop-1 ( q624 ) alters a conserved amino acid in the HMG-box DNA binding domain . [Field: introduction]
 
SECTION: results. The pop-1 ( q645 ) mutation carries a nucleotide substitution predicted to change an aspartic acid ( D ) to a glutamic acid ( E ) ( Fig . 2B ) ; this mutation resides within the pop-1 -catenin binding domain and alters an amino acid conserved in all known TCF / LEF-1 proteins , including nematode , fly , and vertebrate homologues . [Field: results]
 
SECTION: results. The pop-1 ( q645 ) mutation carries a nucleotide substitution predicted to change an aspartic acid ( D ) to a glutamic acid ( E ) ( Fig . 2B ) ; this mutation resides within the pop-1 -catenin binding domain and alters an amino acid conserved in all known TCF / LEF-1 proteins , including nematode , fly , and vertebrate homologues . [Field: results]
 
SECTION: results. The pop-1 ( q624 ) mutation possesses a nucleotide change in the region encoding the HMG box ; the predicted amino acid change in this case also affects a conserved amino acid ( Fig . 2C ) . [Field: results]
 
SECTION: results. The pop-1 ( q624 ) mutation possesses a nucleotide change in the region encoding the HMG box ; the predicted amino acid change in this case also affects a conserved amino acid ( Fig . 2C ) . [Field: results]
 +
 +
Sentence to make:
 +
*Molecular sentence 2: "q624 encodes a D to E change in the catenin binding domain"
 +
*Orthology sentence: "q624 affects a conserved amino acid in the HMG-box DNA binding domain specifically in TCF/LEF-1 type HMG proteins"
 
</pre>
 
</pre>
  
Line 423: Line 484:
 
#Molecular sentence 1
 
#Molecular sentence 1
 
#Molecular sentence 2
 
#Molecular sentence 2
 +
#Disease/Orthology
 
#Process
 
#Process
 
#Phenotype observed
 
#Phenotype observed
 +
#Phenotype attribute
 
#Phenotype NOT observed
 
#Phenotype NOT observed
#Phenotype attribute
 
#Disease orthology
 
  
 
==Postgres sources ==
 
==Postgres sources ==
 
<pre>
 
<pre>
Source files for Tissue expression data for gene concise description
+
Source files for phenotype attribute data for variation concise description
*Source 1: Expression data
+
*OA (app) tables:
*OA (exprpat), PG table names:
+
**app_variation
 +
**app_term
 +
app_paper, app_easescore, app_mmateff, app_hmateff, app_molecule, app_anatomy, app_lifestage, app_penetrance, app_mat_effect, app_temperature, app_cold_degree, app_heat_degree, app+pat_effect
 +
app_haplo, app_cold_sens, app_heat_sens
 +
<pre>
 +
need to adapt for variation concise description
 
**for all these tables where exp_endogenous table value 'endogenous', grab the exp_gene, WBGeneXXXXXXXX
 
**for all these tables where exp_endogenous table value 'endogenous', grab the exp_gene, WBGeneXXXXXXXX
 
**exp_name, values look like Expr1005.
 
**exp_name, values look like Expr1005.
Line 440: Line 506:
 
**exp_paper for paper
 
**exp_paper for paper
 
**exp_qualifier for the qualifiers 'certain', 'uncertain' and 'partial'.
 
**exp_qualifier for the qualifiers 'certain', 'uncertain' and 'partial'.
*Contact Person: Daniela
+
 
 
</pre>
 
</pre>
  

Latest revision as of 01:38, 2 March 2016

Contents

Useful links

app tables
variation model
Ranjana's wiki for creating automated concise descriptions of genes.
geneace upload info
geneace upload of nongene info

Variation concise descriptions

Human-readable summaries of alleles that include a description of its lesion, its effect on the gene's function, and resulting phenotypes. These descriptions aim to recreate summaries like those in the C. elegans I & II books and enhance them with up to date data. A first step is to make and display summaries for each variation; second step is to extract info and combine the summaries of a gene's variations and display them on the corresponding gene pages.

From C. elegans II
e51 : paralysed kinky small irregular pharyngeal pumping able to lay eggs. ES3 ME0. NA > 30
(e450amber e312amber (non-null) e309 (see sup- 6) etc.; all similar to e51 or slightly weaker).
See also e51, e328, e450, e973, e985, e2208, e2274 [C.elegansII] e51 : paralysed, kinky, small,
irregular pharyngeal pumping; able to lay eggs. Ric, high acetylcholine levels; variable
neuroanatomical defects.ES3 ME0. OA>30: e450amb, e312amb (non-null),e309 (suppressed by
sup-6), s69, s178 etc. All alleles similar to e51 or slightly weaker.

MGI produces these summaries (do not know if they are automated): for MGI:95294

Mutations widely affect epithelial development. Null homozygote survival is strain dependent, with
defects observed in skin, eye, brain, viscera, palate, tongue and other tisses. Other  mutations
produce an open eyed, curly whisker phenotype, while a dominant hypermorph yields a thickened
epidermis.

Sample allele summaries:

ju2 is a null allele of syd-1(F32D2.5). The ju2 lesion is a nonsense point mutation that results in a
truncation of all 3 SYD-1 isoforms. ju2 results in defects in axodendritic polarity of ASI and L1 DDs,
neuron morphology of ASI but not DD or VD neurons, presynaptic component localization, synaptic
remodeling of VDs in adults, and backward movement resulting in coiling. ju2 animals do not show
defects in neurite development or postsynaptic component localization.
e1368 is a reduction-of-function/hypomorphic allele of the insulin/IGF receptor ortholog daf-2. The
e1368 lesion is a missense mutation affecting 5 of 6 coding transcripts daf-2. e1368 affects many, but
not all DAF-2-activity requiring processes. Specifically, e1368 disrupts DAF-2 processes of embryonic
and larval development, formation of the developmentally arrested dauer larval stage (diapause),
adult longevity, fat storage, salt chemotaxis learning, and stress resistance, including response to
high temperature. e1368 mutants are temperature sensitive and are dauer constitutive at 22.5 deg. In
addition, e1368 animals have extended life spans. e1368 animals do not show any defects in acetylcholine
esterase activity, carbon dioxide avoidance, diacetyl chemotaxis, and DMPP response.

Source files for project

Building sentences

Building Molecular sentence 1

Template for molecular sentence 1

<variation> is a <app_nature> allele of <gene>.

  • Ex. "ju2 is a null allele of syd-1(F32D2.5)"
  • Ex. "e1368 is a reduction-of-function/hypomorphic allele of daf-2."

Sources for molecular sentence 2

  • Source 1: geneace file on postgres
    • tazendra /home/postgres/work/pgpopulation/obo_oa_ontologies/geneace
  • Source 2: gin_seqname.pg
    • tazendra /home/postgres/work/pgpopulation/obo_oa_ontologies/geneace
  • Source 3: postgres table app_function

Building Molecular sentence 2A - gene features

Gene features include DNA binding sites, promoters, UTRs, splice sites

Template for Molecular sentence -gene features

The <variation> is a <Molecular_change> in <gene feature> in <gene>.

  • Ex. tm3467 is a deletion mutation in a splice acceptor site in supr-1. (WBPaper00045690)

source tags

  1. Molecular_change tags:
                       Splice_site Donor Text #Evidence
                                   Acceptor Text #Evidence
                       Frameshift Text #Evidence  // added sdm

Building Molecular sentence 2B - gene processing

Gene processing effects include, truncation, frameshifts

Template for Molecular sentence -gene processing

The <variation> is a <Molecular_change> in <gene feature> in <gene>.

  • Ex. n3763 is a frameshift mutation in lin-35. (WBPaper00027336)
  • Ex. n767 is a silent mutation in lin-15. (WBPaper00001182)

source tags

  1. Molecular_change tags:
                       Silent Text #Evidence
                       Splice_site Donor Text #Evidence
                                   Acceptor Text #Evidence
                       Frameshift Text #Evidence  // added sdm
                       Readthrough Text #Evidence // klh WS228

Building Molecular sentence 2C - protein domains

Protein domains include catalytic sites, binding domains, activation domains etc.

Template for Molecular sentence -protein domains

The <variation> is a <Molecular_change> in the <protein domain> of <gene>.

  • Ex. gk291 is a deletion mutation in the PTB domain of dab-1. (WBPaper00031546)


Sources for molecular sentence 2

  • Source 1: geneace file on postgres
    • tazendra /home/postgres/work/pgpopulation/obo_oa_ontologies/geneace
  • Source 2: TBD for associated domain

Variation description tags needed for the above text:

  1. Molecular_change tags:
                       Nonsense UNIQUE Amber_UAG Text #Evidence
                                       Ochre_UAA Text #Evidence
                                       Opal_UGA Text #Evidence
                       Missense Text #Evidence                // text fields stored details of codon change
problems
  • coding vs noncoding genes
  • mutation in noncoding area of gene
  • mutation affects isoforms differently
  • only use variations mapped onto human proteins, rather than other way around - keep in sync with with other projects, also limits sentence to a subset of isoforms?
  • ..."that is or is not conserved in humans." can only use under limited situations, orthology needs to be done.

Building gene process summary sentences

Template for a process sentence

<Variation> affects <Gene> function in <GO>.
Example:

  • lf29 affects polk-1 function in error-prone translesion synthesis.
  • bp501 affects atg-4.1 function in autophagy.
  • ns260 affects ttx-1 function in embryo development ending in birth or egg hatching
  • ns235 affects ttx-1 function in the regulation of transcription from RNA polymerase II promoter
  • gg91 affects nrde-2 function in chromatin silencing by small RNA

Source files for process sentences

Gene association file:

WB	WBGene00006831	unc-104		GO:0048490	WB_REF:WBPaper00045884|PMID:25329901	IMP	WB:WBVar02141295	P		C52E12.2|klp-1	gene	taxon:6239	20141212	WB
WB	WBGene00019126	sam-4		GO:1903744	WB_REF:WBPaper00045884|PMID:25329901	IMP	WB:WBVar02125688	P		F59E12.11	gene	taxon:6239	20141212	WB
WB	WBGene00017696	polk-1		GO:0042276	WB_REF:WBPaper00041255|PMID:22761594	IMP	WB:WBVar01473736	P		F22B7.6	gene	taxon:6239	20150611	WB
WB	WBGene00013595	atg-4.1		GO:0006914	WB_REF:WBPaper00041282|PMID:22767594	IMP	WB:WBVar01473704	P		Y87G2A.3	gene	taxon:6239	20140724	WB
WB	WBGene00006652	ttx-1		GO:0009792	WB_REF:WBPaper00040681|PMID:22298710	IMP	WB:WBVar00603928	P		Y113G7A.6	gene	taxon:6239	20140408	WB
WB	WBGene00006652	ttx-1		GO:0045944	WB_REF:WBPaper00040681|PMID:22298710	IMP	WB:WBVar00603924	P		Y113G7A.6	gene	taxon:6239	20140408	WB	has_regulation_target<WB:WBGene00006894>,occurs_in<WBbt:0006754>,happens_during<GO:0009408>
WB	WBGene00011333	nrde-2		GO:0031048	WB_REF:WBPaper00040602|PMID:22231482	IMP	WB:WBVar00601048	P		T01E8.5	gene	taxon:6239	20150715	WB
WB	WBGene00017066	maco-1		GO:0006935	WB_REF:WBPaper00038428|PMID:21589894	IMP	WB:WBVar00597666|WB:WBVar00597667	P		D2092.5	gene	taxon:6239	20110823	WB
WB	WBGene00017066	maco-1		GO:0023041	WB_REF:WBPaper00038428|PMID:21589894	IMP	WB:WBVar00597666|WB:WBVar00597667	P		D2092.5	gene	taxon:6239	20110824	WB

Rules for Process sentence construction

  • Rule 1: Ignore all lines that do no have "IMP" in column 7
  • Rule 2: Map column 8 WBVariation to <allele public name> -
*use obo_name_variation.pg at tazendra /home/postgres/work/pgpopulation/obo_oa_ontologies/geneace
*WBVarID is in first column of geneace file, public_name is second column of geneace file
  • Rule 3: When there are more than one WBVarIDs in column 8, map other WBVarIDs and create a separate summary for those objects
  • Rule 4: Map column 5 GO:ID to GO name -
*use obo_goidprocess at tazendra /home/postgres/work/pgpopulation/obo_oa_ontologies

obo_goidprocess looks like:

GO:ID in line id: <GO:ID#######>
name in line name: <GO name>
If GO:term name starts with a qualifiers "negative" or "positive", replace qualifier with "the"

Example:
js901 affects unc-104 function in anterograde synaptic vesicle transport. Based on column 8 WBVar02141295 ->js901, column 3 unc-104, column 5 GO:00048490
js415 affects sam-4 function in the regulation of anterograde synaptic vesicle transport. Based on column 8 WBVar02125688 -> js415, column 3 sam-4, column 5 GO:1903744 -> positive regulation of anterograde synaptic vesicle transport -> Replace "positive" with "the" -> the regulation of anterograde synaptic vesicle transport

  • Rule 5: Italicize <variation> public name and column 3 gene
  • Rule 6: If there are two variations listed in column 8, make a summary for each variation each using the GO value in column 5 of the line
  • Rule 7: If the genes and alleles are the same in each line, concatenate GO:IDs, comma separate or join with “and”
*Example: 
 *nj21 affects maco-1 function in chemotaxis and neuronal signal transduction
 *nj34 affects maco-1 function in chemotaxis and neuronal signal transduction

Building Phenotype Observed summary sentences using phenotype_association file

Template for Phenotype observed sentences

<Variation> results in (defects, alterations) in <phenotype(s)>.
Ex: "e1368 disrupts DAF-2 processes of embryonic and larval development, formation of the developmentally arrested dauer larval stage (diapause), adult longevity, fat storage, salt chemotaxis learning, and stress resistance, including response to high temperature. In addition, e1368 animals have extended life spans. "

Source files Phenotype Observed data

Source 1 phenotype association file:

1	2	3	4	5	6	7	8	9	10	11	12	13	14	15
WB	WBGene00000898	daf-2		WBPhenotype:0001682	WB:WBVar00143949	IMP	WB:WBPerson261	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2	NOT	WBPhenotype:0001688	WB:WBVar00143949	IMP	WB:WBPerson261	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2		WBPhenotype:0000190	WB_REF:WBPaper00002149	IMP	WB:WBVar00088561	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2	NOT	WBPhenotype:0001660	WB_REF:WBPaper00006052	IMP	WB:WBVar00088561	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2		WBPhenotype:0000136	WB_REF:WBPaper00046188	IMP	WB:WBVar00143947	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2		WBPhenotype:0000631	WB_REF:WBPaper00036280	IMP	WB:WBVar00143947	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2		WBPhenotype:0000637	WB_REF:WBPaper00038179	IMP	WB:WBVar00143947	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2		WBPhenotype:0001184	WB_REF:WBPaper00038379	IMP	WB:WBVar00143947	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2		WBPhenotype:0001351	WB_REF:WBPaper00038379	IMP	WB:WBVar00143947	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2		WBPhenotype:0001861	WB_REF:WBPaper00041295	IMP	WB:WBVar00143947	P		Y55D5A.5	gene	taxon:6239	20151027	WB

Rules for phenotype sentence construction using postgres tables

Rule 1: For lines that does not contain a value in column 4,

  • extract variation(column 6 or 8),
  • phenotype (column 5)
  • paper(column 6)
  • ex. "WB:WBVar00143947" "WBPhenotype:0001861" "WBPaper00041295"
  • Map WBVariationID to Variation public_name using obo_name_variation
  • Map WBPhenotype to Phenotype name using phenotype_ontology.WS251.obo

Rule 2: When more than one variation exists in a line create a new line and use only one variation, with same phenotype, NOT(if exists), and paper as original line
Rule 3: Pool all phenotypes for a given variation, comma separate
Rule 4: If a Phenotype term in the list is a parent of (is_a or part_of parent) another Phenotype term in the list, keep the most granular child term and ignore the parent term(s)


Building Phenotype Observed summary sentences using phenotype_association file

Template for Phenotype observed sentences

<Variation> results in (defects, alterations) in <phenotype(s)>.
Ex: "e1368 effects embryonic and larval development, formation of the developmentally arrested dauer larval stage (diapause), adult longevity, fat storage, salt chemotaxis learning, stress resistance, and response to high temperature. In addition, mutants have extended life spans. "

Source files Phenotype Observed data

Source 1 postgres app tables:

app_term
app_variation
app_paper

Rules for phenotype sentence construction

Rule 1:

  • extract variation - app_variation
  • phenotype - app_term
  • paper - app_paper
  • ex. "WB:WBVar00143947" "WBPhenotype:0001861" "WBPaper00041295"
  • Map WBVariationID to Variation public_name using obo_name_variation
  • Map WBPhenotype to Phenotype name using phenotype_ontology.WS251.obo

Rule 2: When more than one variation exists in a line create a new line and use only one variation, with same phenotype, NOT(if exists), and paper as original line
Rule 3: Pool all phenotypes for a given variation, comma separate
Rule 4: If a Phenotype term in the list is a parent of (is_a or part_of parent) another Phenotype term in the list, keep the most granular child term and ignore the parent term(s)
Rule 5: Remove 'variant' from public names that have them

Rules for specific phenotype terms

Rule 1: For all terms that contain 'variant' remove 'variant' from public names that have them
Rule 2: For the following terms:

  • WBPhenotype:0000061 - extended life span
  • WBPhenotype:0001171 - shortened life span
    • add an "s" to the end of the term public name
    • use the phrasing "In addition, mutants have extended life spans."
  • WBPhenotype:0001838 - drug induced gene expression variant
  • WBPhenotype:0001871 - drug induced life span variant
  • WBPhenotype:0001872 - drug induced locomotion variant
    • change "induced" to "influenced"
  • Terms that end in "early emb"
    • replace "early emb" in the term with "in the early embryo"
    • for term WBPhenotype:0001185 "embryonic developmental delay early emb", remove "embryonic"
    • for term WBPhenotype:0001186 "embryo delayed at pronuclear contact early emb", remove the first term "embryo"

Building Phenotype Attribute summary sentences

Template for Phenotype Attribute summary sentences

<variation> is <app attribute>, <app attribute> <app_term>

  • Ex. "s1019 is cold-sensitive, maternal effect mid larval lethal;"

<variation> is <app attribute> <app_term> at <app_heat_temp> OR <variation> is <app attribute> <app term> at <

  • Ex. "e1368 is temperature sensitive dauer constitutive at 22.5 deg C;"

<variation> is <app attribute> for all phenotypes at <app_heat_degree> OR <variation> is <app attribute> for all phenotypes at <app_cold_degree>

  • Ex. "oj21 is temperature sensitive for all phenotypes at 25 deg C; "

<variation> is <app_mat_effect> <app_term>

  • Ex. "oj21 is maternal effect embryonic lethal;"

Source for Phenotype Attribute sentence

postgres app tables

Rules for Phenotype Attribute summary sentences

Rule 1: when there are more than one phentoype attribute sentences, use the generic "animals" instead of repeating the allele name

  • Ex "oj21 is temperature sensitive for all phenotypes at 25 deg C; oj21 is maternal effect embryonic lethal; animals are 100% sterile at 25 degrees C;"

Building Phenotype NOT Observed summary sentences

Template for Phenotype NOT observed sentences

<Allele> does not show (defects, alterations) in <NOT phenotype(s)>.

  • Ex. "e1368 animals do not show any defects in acetylcholine esterase activity, carbon dioxide avoidance, diacetyl chemotaxis, and DMPP response."

Source files Phenotype Observed data

Source 1 phenotype association file:

1	2	3	4	5	6	7	8	9	10	11	12	13	14	15
WB	WBGene00000898	daf-2		WBPhenotype:0001682	WB:WBVar00143949	IMP	WB:WBPerson261	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2	NOT	WBPhenotype:0001688	WB:WBVar00143949	IMP	WB:WBPerson261	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2		WBPhenotype:0000190	WB_REF:WBPaper00002149	IMP	WB:WBVar00088561	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2	NOT	WBPhenotype:0001660	WB_REF:WBPaper00006052	IMP	WB:WBVar00088561	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2		WBPhenotype:0000136	WB_REF:WBPaper00046188	IMP	WB:WBVar00143947	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2		WBPhenotype:0000631	WB_REF:WBPaper00036280	IMP	WB:WBVar00143947	P		Y55D5A.5	gene	taxon:6239	20151027	WB
WB	WBGene00000898	daf-2		WBPhenotype:0000637	WB_REF:WBPaper00038179	IMP	WB:WBVar00143947	P		Y55D5A.5	gene	taxon:6239	20151027	WB

Rules for phenotype sentence construction

Rule 1: For each line that contains (NOT) value in column 4, extract

  • variation(column 6 or 8),
  • phenotype (column 5)
  • paper(column 6)
  • NOT(column 4)
  • ex. "WB:WBVar00143947" "NOT" "WBPhenotype:0000114" "WBPaper00039871"
  • Map WBVariationID to Variation public_name using obo_name_variation
  • Map WBPhenotype to Phenotype name using phenotype_ontology.WS251.obo

Rule 2: When more than one variation exists in a line create a new line and use only one variation, with same phenotype, and paper as original line
Rule 3: Pool all NOT phenotype for a given variation, separate
Rule 4: If a Phenotype term in the list is a parent of (is_a or part_of parent) another Phenotype term in the list, keep the most granular child term and ignore the parent term(s) Rule 5: Remove 'variant' from public names that have them


Building Disease Orthology summary sentences

see Caltech group meeting May 7, 2015

  • to connect conserved/syntenic mutations
  • link elegans gene variations and phenotypes to homologous human disease gene variations
  • to link elegans mutations as a disease model ex. pdr-1 mutations used to model juvenile parkinsons

use ortholog(s) of gene defined by Generation_of_automated_descriptions#Orthology.2FHomology Orthology, Homology and Paralog data in WormBase

Examples for concise descriptions for variations of different types

  • Classic alleles

notes: can add: mutagen, history of isolation

    • Alleles with molecular data
e1368 is a reduction-of-function/hypomorphic allele of the insulin/IGF receptor ortholog daf-2. The
e1368 lesion is a missense mutation affecting 5 of 6 coding transcripts daf-2. e1368 affects many, but
not all DAF-2-activity requiring processes. Specifically, e1368 disrupts DAF-2 processes of embryonic
and larval development, formation of the developmentally arrested dauer larval stage (diapause),
adult longevity, fat storage, salt chemotaxis learning, and stress resistance, including response to
high temperature. e1368 mutants are temperature sensitive and are dauer constitutive at 22.5 deg. In
addition, e1368 animals have extended life spans. e1368 animals do not show any defects in acetylcholine
esterase activity, carbon dioxide avoidance, diacetyl chemotaxis, and DMPP response.
    • Alleles with only genetic data
  • Other variation types
  • Engineered alleles
  • Integrated transgenes

other categories of alleles

  • Most published alleles
  • Alleles with most phenotypes
  • Alleles of genes with concise descriptions (see concise description wiki to find these)

Prioritizing variations for automated descriptions

  • Classic alleles - Variations with Variation_type Allele (see Variation model)
    • Alleles with molecular data => Variation_type Allele + Type_of_mutation exists
    • Alleles with only genetic data => Variation_type Allele and NO Type_of_mutation exists
  • Variations of genes with concise descriptions
    • Variation Affects Gene + gene exists with cns_summary table entry; acedb model Gene->Gene_info->Concise_description
  • Other variation types
    • Variation_type SNP, Confirmed_SNP
    • Variation_type Transposons, RFLPs
  • Engineered variations
    • Variation_type Engineered_allele
  • Integrated transgenes with allele name
  • Variations that have been most published
    • textpresso search results
  • Variations with most phenotypes
    • app_variation count

Orthology/ Conserved domain mutations

see Caltech group meeting May 7, 2015
connections between mutations and protein domains, and predict affects on function
We currently do not capture mutations in the context of affecting a conserved amino acid - how and who would do this? Can Hinxton generate these?
Many examples can be found with the Textpresso search for 'mutation conserved'

Examples

id : WBPaper00037661
name : WBPaper00037661
title : Sequential action of Caenorhabditis elegans Rab GTPases regulates phagolysosome formation during apoptotic cell degradation.
Sequencing of rab-14 in qx18 mutants revealed a C to T transition, which resulted in substitution of the Threonine at codon 67 with Methionine (ACG > ATG; T67M). This mutation affects the phosphate/Mg2+
binding domain PM3, which is conserved in all members of the Ras GTPase superfamily

Sentences to make: 
*Molecular sentence 2: "qx18 encodes a C to T transition, T67M which affects the phosphate/Mg2+ binding domain PM3" 
*Orthology sentence: "The phosphate/Mg2+ binding domain PM3 is conserved in all members of the Ras GTPase superfamily"
Reverse in vitro mutation analysis of elegans mutation on mammalian disease gene.
Title: Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro .
Authors: Van Etten RA ; Debnath J ; Zhou H ; Casasnovas JM
Journal: Oncogene
Year: 1995-05-18
Doc ID: WBPaper00002191
When the n1619 mutation , which confers a lethal and highly penetrant vulvaless phenotype in C . elegans , is introduced into the c-abl SH3 domain , substituting a leucine for proline at AN amino acid number 131 , the resulting mutant transforms NIH3T3 fibroblasts with an efficiency about 10 % that of SH3-deleted c-abl .

Sentence to make: 
*Molecular sentence 2: "n1619 encodes a L131P substitution in the c-abl SH3 domain"
Title: CED-9 and mitochondrial homeostasis in C . elegans muscle .
Authors: Tan FJ ; Husain M ; Manlandro CM ; Koppenol M ; Fire AZ ; Hill RB
Journal: J Cell Sci
Year: 2008-10-15
Doc ID: WBPaper00032231
SECTION: results. This allele encodes a mutation where glycine 169 in the BH3 binding pocket is replaced with glutamate ( Fig . 4C ) ( Hengartner and Horvitz , 1994a ) , which inhibits EGL-1 from binding and triggering a conformational change in CED-9 ( del Peso et al . , 2000 ; Yan et al . , 2004 )
SECTION: results. In the gain-of-function ced-9 ( n1950sd ) allele , glycine 169 , which resides in the CED-9 BH3 binding pocket , is mutated to glutamate ( G169E ) . [Field: results, subscore: 3.00]
SECTION: results. To test whether co-expression of DRP-1 modulates CED-9 via interactions with the BH3 binding pocket , we first created a construct corresponding to the ced- 9 ( n1950gf ) allele .

Sentence to make: 
*Molecular sentence 2: "n1950 encodes a G169E change in the BH3 binding pocket of CED-9"
WBPaper00029156 Modzelewska 2007
“the sy262 mutation lies within the Rac GEF Dbl domain , it is possible that the mutation acts through one or both of the GTPases .”
“In conjunction with molecular modeling , our data suggest that the C . elegans mutation as well as an equivalent mutation in human SOS1 activate the MAPK pathway by disrupting an auto-inhibitory function of the Dbl domain on Ras activation “
“A mutation equivalent to sy262 G322R activates hSOS1.”
“...in every experiment we found that at some time point, hSOS1 C282R dis- played two- to fourfold more activity than wild-type hSOS1. In conjunction with our genetic data, these data suggest that the G322R change in C. elegans SOS-1, as well as the equivalent C282R change in hSOS1, does indeed enhance EGF-dependent MAPK activation.”

Sentence to make: 
*Molecular sentence 2: "sy262 encodes a G33R mutation in the Rac GEF Dbl domain and is equivalent to a C282R change in the human hSOS1."
*Orthology sentence: "The sy262 G33R mutation is equivalent to a C282R change in the human hSOS1."
Title: The genetics of ivermectin resistance in Caenorhabditis elegans .
Authors: Dent JA ; Smith M ; Vassilatis DK ; Avery L
Journal: Proc Natl Acad Sci U S A
Year: 2000-03-14
Doc ID: WBPaper00003954
results. The region surrounding the conserved valine ( bold ) that is mutated to a glutamate in the ad1302 allele ( resulting from a T to A mutation in the second base of the V60 codon ) is shown lined up with the corresponding region in other GluCl subunits and in the rat glycine and -aminobutyric acid ( GABA ) type A- channel subunits ( 29 , 30 ) . [Field: results]

Sentence to make: 
*Molecular sentence 2: "ad1302 encodes a Val to Glu change."
*Orthology sentence: "ad1302 affects a region that is conserved in GluCl subunits as well as in rat glycine and GABA type A-channel subunits."
Title: POP-1 controls axis formation during early gonadogenesis in C . elegans .
Authors: Siegfried KR ; Kimble J
Journal: Development
Year: 2002-01
Doc ID: WBPaper00005116
SECTION: abstract. The pop-1 ( q624 ) allele is weakly penetrant for multiple defects and appears to be a partial loss-of-function mutation ; pop-1 ( q624 ) alters a conserved amino acid in the HMG-box DNA binding domain . [Field: abstract]
SECTION: discussion. This mutation alters a conserved amino acid in the HMG box DNA binding domain which is conserved specifically in TCF / LEF- 1 type HMG proteins ( Laudet et al . , 1993 ) , suggesting that the pop-1 ( q624 ) mutation may affect either recognition of the TCF / LEF-1 consensus sequence or DNA binding affinity , thereby lowering POP-1 activity . [Field: discussion]
SECTION: discussion. As the only mutation isolated thus far in a developmental system that changes a highly conserved amino acid in the -catenin binding domain , the pop-1 ( q645 ) missense mutation may shed new light on TCF / LEF-1 function during development . [Field: discussion]
SECTION: introduction. The pop-1 ( q624 ) allele is weakly penetrant for multiple defects and appears to be a partial loss-of function mutation ; pop-1 ( q624 ) alters a conserved amino acid in the HMG-box DNA binding domain . [Field: introduction]
SECTION: results. The pop-1 ( q645 ) mutation carries a nucleotide substitution predicted to change an aspartic acid ( D ) to a glutamic acid ( E ) ( Fig . 2B ) ; this mutation resides within the pop-1 -catenin binding domain and alters an amino acid conserved in all known TCF / LEF-1 proteins , including nematode , fly , and vertebrate homologues . [Field: results]
SECTION: results. The pop-1 ( q624 ) mutation possesses a nucleotide change in the region encoding the HMG box ; the predicted amino acid change in this case also affects a conserved amino acid ( Fig . 2C ) . [Field: results]

Sentence to make: 
*Molecular sentence 2: "q624 encodes a D to E change in the catenin binding domain" 
*Orthology sentence: "q624 affects a conserved amino acid in the HMG-box DNA binding domain specifically in TCF/LEF-1 type HMG proteins"

Location of project-related files

on Textpresso-dev

The directory structure should be something like

  • descriptions/ (descriptions and stats per release)
  • source_files/ (common input files, including variation. gene, obos, etc)
  • molecular/ (phrases generated from molecular info input)
  • process/ (phrases generated from go input)
  • phenotype/ (phrases generated from phenotype input)

on postgres

  • The latest dump:
  • Variation concise description pipeline:
  • Scripts:
  • Output location:

Order of sentences

  1. Molecular sentence 1
  2. Molecular sentence 2
  3. Disease/Orthology
  4. Process
  5. Phenotype observed
  6. Phenotype attribute
  7. Phenotype NOT observed

Postgres sources

Source files for phenotype attribute data for variation concise description
*OA (app) tables:
**app_variation
**app_term
app_paper, app_easescore, app_mmateff, app_hmateff, app_molecule, app_anatomy, app_lifestage, app_penetrance, app_mat_effect, app_temperature, app_cold_degree, app_heat_degree, app+pat_effect
app_haplo, app_cold_sens, app_heat_sens
<pre>
need to adapt for variation concise description
**for all these tables where exp_endogenous table value 'endogenous', grab the exp_gene, WBGeneXXXXXXXX
**exp_name, values look like Expr1005.
**exp_anatomy for anatomy terms, in the form of Wbt:0003679, translate these IDs using the anatomy ontology file
**anatomy ontology file from ftp site:ftp://ftp.sanger.ac.uk/pub/wormbase/releases/WS244/ONTOLOGY/anatomy_ontology.WS244.obo
**exp_paper for paper
**exp_qualifier for the qualifiers 'certain', 'uncertain' and 'partial'.

Preliminary results

Mapping of automated variation concise description data to OA fields

Mapping of data to data fields in the OA using table name vcd for variation concise description
OA field
number
OA field name Data to be inserted Example of data
to be inserted
Required or Not OA table name
1 WBVariation Variation WBVar00145853 OR gk448 Required vcd_variation
2 Species Species Onchocerca volvulus Required vcd_species
3 Curator Name of Curator James Done(first then replace with) Karen Yook
(insert for all rows)
Required vcd_curator
4 Curator History Name of Curator same as pgid
(insert for all rows)
Required vcd_curhistory
5 Description Type Automated_concise_description
(insert for all rows)
Automated_concise_description Required vcd_desctype
6 Description Text the automated concise description asp-19 encodes an ortholog... Required vcd_desctext
7 Reference WBPaper WBPaper00026979 Required vcd_paper
8 Last Updated Date when the descriptions
were last generated
2014-09-11 Required vcd_lastupdate
9 pgid pgid 1149
(Postgres will generate)
Required

Tab-delimited file for OA insert

(for gene concise desc, for reference)

  • One tab-delimited file per species
  • Order of the data will be: WBGene, Date, Paper, Accession_evidence, Automated_concise_description, Species, Inferred_automatically text
  • Format: tab-delimited file, comma separate the values when multiple values are present
  • Date is the last date that the script was run to generate the automated descriptions (eg. 2014-05-28)
  • File will be placed on textpresso-dev to be picked up by a cron job by JC

Directory structure for project

Use same structure as for gene concise descriptions (which follows)

Inserting automated descriptions into postgres

Populating script

Scripts for automated concise descriptions (for reference)

  • /home/acedb/ranjana/concise_testing/populate_automated_concise_descriptions.pl -> /home/postgres/work/pgpopulation/concise_description/20140909_automated_concise/populate_automated_concise_descriptions.pl

which look at

For testing on Mangolassi

Dumping to .ace

Tracking progress

Generate a report for numbers and place on Textpresso-dev

  • Report for each upload:
  • Total number of automated variation descriptions =
  • Number of automated descriptions with molecular details =
  • Number of automated descriptions with gene function/GO information =
  • Number of automated descriptions with phenotype information =
  • Number of automated descriptions with human disease reference =

Changes/Updates for each release

Issues to address

Automated descriptions software

Follow gene concise description pipeline Documentation for workflow and scripts

Publications related to Text-mining methods

  • Automatically generating gene summaries from biomedical literature. Ling X, Jiang J, He X, Mei Q, Zhai C, Schatz B. Pac Symp Biocomput. 2006:40-51. PMID:17094226
  • Generating gene summaries from biomedical literature: A study of semi-structured summarization. Xu Ling *, Jing Jiang, Xin He, Qiaozhu Mei, Chengxiang Zhai, Bruce Schatz